Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis

Details for Australian Patent Application No. 2006242311 (hide)

Owner Novartis AG

Inventors Alland, Leila; Mestan, Jurgen; Fabbro, Doriano; Manley, Paul W.

Agent Davies Collison Cave

Pub. Number AU-B-2006242311

PCT Pub. Number WO2006/119154

Priority 60/676,740 02.05.05 US

Filing date 1 May 2006

Wipo publication date 9 November 2006

Acceptance publication date 4 March 2010

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119154 Priority application(s): WO2006/119154

4 March 2010 Application Accepted

  Published as AU-B-2006242311

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242334-Molded lead frame connector with one or more passive components

2006242308-Timed, pulsatile release systems